Enlivex Therapeutics
ENLV
ENLV
18 hedge funds and large institutions have $1.41M invested in Enlivex Therapeutics in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
51% less capital invested
Capital invested by funds: $2.89M → $1.41M (-$1.48M)
67% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 6
Holders
18
Holding in Top 10
–
Calls
$2.4M
Puts
$552K
Top Buyers
| 1 | +$168K | |
| 2 | +$88K | |
| 3 | +$57.6K | |
| 4 |
Morgan Stanley
New York
|
+$50.1K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$24.2K |
Top Sellers
| 1 | -$1.66M | |
| 2 | -$99K | |
| 3 | -$22.5K | |
| 4 |
Group One Trading
Chicago,
Illinois
|
-$9.92K |
| 5 |
SIGI
Susquehanna International Group (Ireland)
Dublin,
Ireland
|
-$7.13K |